home > about us
Simcyp is a research-based company providing predictive pharmacokinetic and pharmacodynamic tools, workshops and consultancy services.
Simcyp's user-friendly simulator and databases predict drug absorption, clearance, distribution and metabolic drug-drug interactions from in vitro data. By simulating pharmacokinetics in virtual patient populations and identifying individuals at extreme risk, the Simcyp Simulator is able to accelerate drug discovery and development.
Simcyp’s clients include many of the major global pharmaceutical and bioscience companies, leading academic institutes and regulatory authorities. These clients form the Simcyp Consortium, which together with an independent International Scientific Advisory Board, guide scientific development at Simcyp.
In support of its development, Simcyp obtains grants to fund research, recruitment and expert activities. Funding bodies include: the European Union, the UK’s Department of Trade and Industry, and the European Framework 6.